Monday 21st July 2025

Bayer says it is putting aside more than $4.5 Billion dollars for future lawsuits about Roundup but stresses the product will remain available for farmers.

This spring, a judge rejected Bayer’s plan to limit the cost of settlements in claims that its glyphosate product cause non-Hodgkins lymphoma.

In a call with investors (this morning), Bayer officials say they will file a petition with the U.S. Supreme Court to review the lower court ruling in favor of Roundup user Edwin Hardeman.

   

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

*